ASPARGO LABORATORIES
Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.Spray formulation offers convenient drug administration, flexible-dose titration, and accessibility for patients with dysphagia (trouble swallowing). The company develops patient-focused solutions and medicines by combining their innovative science and technology. Its initial product candidate is a proprietary oral suspension spray formulation of sildenafil citrate, the active ingredient in VIAGRACurrently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia, and China. Applications for approval are planned for Croatia, France, Germany, and Austria.
ASPARGO LABORATORIES
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Englewood, New Jersey, United States
Country:
United States
Website Url:
http://www.aspargolabs.com
Total Employee:
1+
Status:
Active
Contact:
201-408-4831
Email Addresses:
[email protected]
Total Funding:
67.9 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome Cloudflare JS CDN JS Gravity Forms
Similar Organizations
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Enterin
Philadelphia-based biotechnology company .
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Founder
Official Site Inspections
http://www.aspargolabs.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aspargo Laboratories"
About – Aspargo Laboratories Inc.
The Global Leadership Team at Aspargo Labs consists of experts from the pharmaceutical, biotechnology, and consumer product industries. With decades of experience, in the development and commercialization of innovative …See details»
Aspargo Laboratories Inc. – Oral suspension …
Cookies are important to you because they affect your browsing experience and help protect your privacy. We use our own and third-party cookies to analyze our services and show you advertising that matches your preferences based on a …See details»
Investors – Aspargo Laboratories Inc.
Nov 19, 2024 Aspargo Labs’ business model is repeatable and applies our proprietary technology to the world’s most meaningful compounds and brands. Current and near-term …See details»
Aspargo Laboratories - Crunchbase Company Profile
Contact Email [email protected] Phone Number 201-408-4831 Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.Spray formulation offers convenient drug administration, flexible-dose titration, and …See details»
Aspargo Laboratories, Inc. | LinkedIn
Aspargo Laboratories, Inc. is a clinical-stage biopharmaceutical company developing patient-focused solutions and must-have medicines by combining our innovative science and technologies and FDA ...See details»
Aspargo Laboratories - PitchBook
Aspargo Laboratories General Information Description. Developer of an oral spray designed to treat erectile dysfunction. The company's oral spray is a formulation of sildenafil, the active ingredient in Viagra, enabling people with erectile …See details»
Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects …
Sep 19, 2023 Cliantha Research, Aspargo’s designated clinical contract research organization, is conducting the “crossover” study in 47 volunteers. Each subject is receiving ASP-001 and …See details»
Aspargo Laboratories Announces IND Clearance by U.S. FDA, …
Sep 5, 2023 Aspargo Laboratories, Inc. Company plans to initiate clinical trials in September 2023 to compare Sildenafil Oral Spray to Viagra® tablets, and effect of dose administration …See details»
Aspargo Labs
Weitere Informationen finden Sie auf unserer globalen Website: https://aspargolabs.com Therapietreue durch Hightech-Dispenser Aspargo Labs ist auch führend in der Entwicklung …See details»
Aspargo Laboratories Announces IND Clearance by U.S. FDA, …
Sep 5, 2023 Aspargo is the exclusive licensee of the patent rights covering Sildenafil Spray for the US and many international markets from Farmalider, S.A. (www.farmalider.com). For …See details»
Aspargo Labs Announces Data on First Oral Spray for Erectile ...
NEW YORK, July 30, 2024--Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on transforming drug delivery with innovative …See details»
Aspargo Laboratories Announces IND Clearance by U.S. FDA
Sep 5, 2023 Aspargo Laboratories, Inc. announced today that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) …See details»
Careers – Aspargo Laboratories Inc.
17 State Street, Suite 3220, New York, NY 10004 | 646-503-1260See details»
Aspargo Laboratories, Inc. Announces Successful Completion of …
May 4, 2020 Aspargo Laboratories, Inc. (Aspargo), a privately held, clinical stage pharmaceutical company, today announced the results of its pre-Investigational New Drug (pre …See details»
Aspargo Laboratories Announces IND Clearance by U.S. FDA,
Sep 5, 2023 1 1Rastrelli G, Maggi M. Erectile dysfunction in fit and healthy young men: psychological or pathological? Transl Androl Urol. 2017 Feb;6(1):79-90. doi: 10.21037/tau ...See details»
Aspargo Labs Appoints Chief Marketing Officer
Nov 19, 2024 [email protected]. Investor & media contacts: Russo Partners Nic Johnson or Liz Phillips (347) 956-7697. [email protected] …See details»
Aspargo Laboratories, Inc. - Facebook
Aspargo Laboratories, Inc. 46 likes. Aspargo Labs is a clinical-stage biopharmaceutical company developing patient-focused solutions andSee details»
Aspargo Laboratories, Inc. Announces Filing of Its Investigational …
Aug 1, 2023 Aspargo Laboratories, Inc. Planned bioequivalence study in healthy adult male subjects will compare the rate and extent of absorption of ASP-001 (Sildenafil Oral Spray) …See details»
Pipeline – Aspargo Laboratories Inc.
The creation of a next generation user-friendly oral medicine delivery device with mobile connectivity software. It will enable precise dosing and encourage adherence while providing …See details»
Aspargo Laboratories Inc. Announces Completion of Dosing of All ...
Dec 5, 2023 $99 Billion Bet: Warren Buffett Invests Heavily In 2 Stocks Expected To Jump 19% And 20%, Wall Street Analysts Predict. Warren Buffett's investment strategy is a case study in …See details»